When an extensive measles epidemic broke out in Turku in late 1975, the availability of a
previous study on measles vaccination reactions in 442 children permitted a comparative …

Measles is known as one of the most infections and persistent of human viral diseases. Its
distribution is worldwide and it causes disease in any climate and under any condition …

Background The majority of infants will not be protected by maternal antibodies until their
first measles vaccination, between 12 and 15 months of age. This provides incentive to …

The efficacy of two measles vaccine schedules was tested in a double-blind, placebo-
controlled field trial. One group of children received three injections of 0.5 ml of inactivated …

Measles vaccination of infants younger than 1 year of age should be successful in
populations with a high proportion of measles vaccinated mothers. Infants whose mothers …

Further-attenuated strains of measles virus may be distinguished from virulent strains by the
following characteristics. Unlike virulent strains, attenuated strains of measles virus can be …

Objective To assess the efficacy of the current measles immunization schedule in Papua
New Guinea, which is to give the first dose at 6 months of age and the second at 9 months …

Introduction and objectives The MMR vaccine was included in the official vaccination
schedule in Spain in 1981. Currently, most women of childbearing age are vaccinated and …

In the interval 1961 to 1963 more than 5,000 children in our series received measles
vaccines by one of three immunization schedules. 1 More than 90% of recipients were …

Objectives. In the United States, younger women are more likely to have immunity to
measles from vaccination and are less likely to have been exposed to the wild virus than are …